A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates
Condition: Poliomyelitis Interventions: Biological: vaccination with novel OPV2 candidate 1 vaccine; Biological: vaccination with novel OPV2 candidate 2 vaccine; Biological: Placebo (Sirupus simplex, Propylenglycolum,. European Pharmacopoeia (Ph.Eur.)) Sponsors: Pierre Van Damme; Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; PATH; Celerion Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials